LYMA REPORTS STRONG 2025 PERFORMANCE WITH $48M REVENUE AS US EXPANSION DRIVES GROWTH
PR Newswire —
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- LYMA, the luxury regenerative MedTech company, today revealed its financial results for the year ending 31 December 2025, reporting revenues of $48 million and EBITDA of $7 million, marking a year of significant growth driven by successful expansion...